FIELD: chemistry.
SUBSTANCE: invention relates to biochemistry and immunology and can be used in biomedical industry when producing drugs for preventing or treating cancerous diseases. A novel peptide is obtained, which can selectively bind to a HLA-A*3303 molecule, which is a WT-1 transcription factor fragment and is characterised by the amino acid sequence Ser-Asp-Gln-Leu-Lys-Arg-His-Gln-Arg The invention discloses agents for obtaining said peptide through a recombinant DNA method and also discloses use thereof as a basic component in induction of WT1 - specific cytotoxic limphocytes.
EFFECT: obtaining a novel peptide.
4 cl, 8 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HLA-A*1101-LIMITED PEPTIDE WT1 AND PHARMACEUTICAL COMPOSITION THAT CONTAINS IT | 2007 |
|
RU2481398C2 |
| VACCINATIVE TUMOR VACCINE COMPOSITION | 2008 |
|
RU2682726C2 |
| VACCINE COMPOSITION FOR MALIGNANT TUMOR | 2013 |
|
RU2721574C2 |
| ANTIGEN-SPECIFIC HELPER T-CELL RECEPTOR GENES | 2013 |
|
RU2680588C2 |
| HELPER PEPTIDE FOR CANCER ANTIGEN | 2010 |
|
RU2588442C2 |
| CDH3-PEPTIDE AND DRUG PREPARATION CONTAINING IT | 2008 |
|
RU2483078C2 |
| PEPTIDE OBTAINED FROM DEPDC1 AND VACCINE CONTAINING IT | 2016 |
|
RU2765574C2 |
| KOC1-DERVIED PEPTIDE AND VACCINE INCLUDING SAME | 2015 |
|
RU2699542C2 |
| CDCA1-DERIVED PEPTIDE AND VACCINE CONTAINING SAME | 2015 |
|
RU2699543C2 |
| CDC45L PEPTIDES AND VACCINES CONTAINING SAME | 2010 |
|
RU2562160C2 |
